A Study of NX-1607 in Adults With Advanced Malignancies
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Linda Neuman, MD
Nurix Therapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Marsden Hospital Nhs Foundation Trust
Sutton, Surrey, United Kingdom
Recruiting - Addenbrookes Cambridge University Hospital
Cambridge, United Kingdom
Recruiting - Beatson West of Scotland Cancer Centre
Glasgow, United Kingdom
Recruiting - Sarah Cannon Research Institute
London, United Kingdom
Recruiting - the Christie Nhs Foundation Trust
Manchester, United Kingdom
Recruiting - Northern Centre for Cancer Care
Newcastle, United Kingdom
Recruiting - Churchill Hospital
Oxford, United Kingdom
Completed
- City of Hope
Duarte, California, United States
Completed - University of Southern California
Los Angeles, California, United States
Recruiting - University of California, San Francisco
San Francisco, California, United States
Recruiting - University of Colorado School of Medicine
Aurora, Colorado, United States
Wells Messersmith, MDRecruiting - University of Chicago
Chicago, Illinois, United States
Recruiting - University of North Carolina
Chapel Hill, North Carolina, United States
Recruiting - University of Oklahoma
Oklahoma City, Oklahoma, United States
Recruiting - Md Anderson Cancer Center
Houston, Texas, United States
Recruiting - University of Virginia
Charlottesville, Virginia, United States
Recruiting - Fred Hutchinson Cancer Center
Seattle, Washington, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Sept 2021
- Primary completion
- 31 Aug 2026
- Completion
- 28 Feb 2028
- Last update posted
- 9 Sept 2025
- Registered enrollment
- 345
- Registry id
- NCT05107674
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.